Prospective phase II study of stereotactic body radiation therapy using helical tomotherapy for stage IA non-small cell lung cancer.
Phase 2
- Conditions
- stage IA non-small cell lung cancer
- Registration Number
- JPRN-UMIN000001721
- Lead Sponsor
- Aichi Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
interstitial pneumonitis, lung fibrosis active infection active multiple cancer (last 3 years) pregnancy or breast feeding psychological disorder systemic steroid medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year overall survival rate
- Secondary Outcome Measures
Name Time Method overall survival time, relapse-free survival time, local pregression-free survival time, 3-year local progression free rate, type of recurrence, acute adverse event, late adverse event, ratio of severe adverse event